Windlas Biotech Ltd share price logo

Windlas Biotech Share Price

NSE: WINDLAS

BSE: 543329

Small Cap

Healthcare Sector

₹765.00

-15.15

(-1.94%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Windlas Biotech Stock Performance

as on March 27, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹747.10
    ₹779.00
    downward going graph

    2.34%

    Downside

    1.83%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹697.40
    ₹1,140.00
    downward going graph

    8.84%

    Downside

    49.02%

    Upside

    downward going graph

Windlas Biotech share price movements today

Previous Close
₹780.15
Open
₹779.00
Volume
49.12K
Upper Circuit
₹936.15
Lower Circuit
₹624.15
Day's Low - High
₹747.10 - ₹779.00
52 Week Low - High
₹697.40 - ₹1,140.00

Windlas Biotech Historical Returns

1 Month Return
+ 3.33 %
3 Month Return
+ 1.17 %
1 Year Return
-25.32 %
3 Year Return
+ 229.73 %
5 Year Return
+ 91.61 %

Windlas Biotech Fundamentals

as on March 27, 2026 at 4:01 pm IST

Market Cap

₹1,646.60 Cr

Return on Equity (ROE)

12.69

PE Ratio (TTM)

24.53

Return on capital employed (ROCE)

16.79

Industry PE ratio

40.67

Beta (LTM)

0.88

P/B Ratio

4.31

Dividend Yield

0.56

PEG Ratio

11.05

Quarterly Earnings Growth YOY

-3.72

EPS (TTM)

29.1

Sector

Pharmaceuticals

Book Value

241.3

Technical Analysis

Bearish

View Technical Analysis

Windlas Biotech Stock Valuation

as on March 27, 2026 at 4:01 pm IST

Windlas Biotech in the last 5 years

  • Overview

  • Trends

Lowest (10.46x)

March 28, 2023

Today (24.53x)

March 25, 2026

Industry (40.67x)

March 25, 2026

Highest (38.93x)

December 6, 2024

LowHigh

Today’s Price to Earnings Ratio: 24.53x

Windlas Biotech Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Windlas Biotech with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Windlas Biotech Ltd image
Windlas Biotech Ltd
NA1,646.6018.32%0.5360759
Welcure Drugs & Pharmaceuticals Ltd image
Welcure Drugs & Pharmaceuticals Ltd
NA32.1310.59%0.00NANA
Amrutanjan Health Care Ltd image
Amrutanjan Health Care Ltd
NA1,501.04-1.23%0.00NANA
Zim Laboratories Ltd image
Zim Laboratories Ltd
NA341.06-2.04%0.6612379
Denis Chem Lab Ltd image
Denis Chem Lab Ltd
NA87.8712.81%0.008173
See all

Windlas Biotech Stock’s Investor Sentiment and Interest

Search interest for Windlas Biotech Ltd Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:6% versus previous 30 day period

Windlas Biotech Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
140.71
144.79
152.67
162.21
171.29
175.15
187
195.02
202.71
210.09
222.4
233.1
Other Income
2.33
2.62
3.24
3.16
4.44
4.13
4.84
4.11
4.94
5.24
3.65
4.57
Total Income
143.05
147.41
155.91
165.38
175.73
179.29
191.84
199.13
207.64
215.33
226.04
237.67
Expenses
124.27
127.64
133.99
141.88
149.28
154.27
163.95
170.39
177.16
183.57
193.84
208.73
Operating Profit
16.44
17.15
18.68
20.33
22.01
20.88
23.05
24.63
25.55
26.52
28.56
24.37
Operating Profit Margin %
11.68%
11.84%
12.24%
12.53%
12.85%
11.92%
12.33%
12.63%
12.6%
12.62%
12.84%
10.45%
Profit Before Interest, Tax and Depreciation
18.77
19.77
21.93
23.5
26.45
25.01
27.89
28.74
30.49
31.76
32.2
28.95
Interest
0.17
0.24
0.29
0.31
0.28
0.49
1.1
1.46
1.33
1.06
1.02
1.28
Depreciation
3.57
3.19
3.33
3.39
3.54
6.21
6.5
6.94
8.34
7.45
7.6
7.7
Profit Before Tax
15.03
16.34
18.31
19.8
22.63
18.31
20.29
20.34
20.82
23.25
23.58
19.97
Tax Paid
3.6
4.27
4.28
4.71
5.64
4.83
4.63
4.76
4.55
5.59
5.79
4.97
Profit After Tax
11.44
12.07
14.03
15.1
16.99
13.48
15.66
15.58
16.28
17.66
17.8
15
Total Net profit including share of profit / Loss from associate company
11.44
12.07
14.03
15.1
16.99
13.48
15.66
15.58
16.28
17.66
17.8
15
EPS
5.37
5.79
6.75
7.26
8.17
6.47
7.49
7.45
7.77
8.43
8.48
7.12
Actual EPS
5.37
5.79
6.75
7.26
8.17
6.47
7.49
7.45
7.77
8.43
8.48
7.12
Adjusted EPS
5.37
5.79
6.75
7.26
8.17
6.47
7.49
7.45
7.77
8.43
8.48
7.12
Diluted EPS
5.37
5.79
6.75
7.26
8.14
6.47
7.43
7.38
7.69
8.34
8.4
7.05

Windlas Biotech Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
352.21
307.27
328.85
427.6
465.93
513.08
630.96
759.88
Other Income
4.33
53.8
2.49
8.74
6.71
9.97
13.47
18.02
Total Income
356.54
361.07
331.34
436.34
472.64
523.05
644.42
777.9
Expenses
312.87
269.53
294.85
400.35
413.51
452.86
552.78
665.77
Operating Profit
39.34
37.74
34
27.25
52.42
60.22
78.18
94.11
Operating Profit Margin %
11.17%
12.28%
10.34%
6.37%
11.25%
11.74%
12.39%
12.38%
Profit Before Interest, Tax and Depreciation
43.67
91.54
36.49
36
59.13
70.19
91.64
112.13
Interest
6.47
4.84
2.53
1.29
1.42
0.79
1.11
4.38
Depreciation
17.35
10.59
9.29
12.97
12.15
12.36
13.44
27.99
Profit Before Tax
19.85
76.11
24.67
21.74
45.56
57.04
77.09
79.76
Tax Paid
8.65
12.3
8.45
6.17
7.47
14.41
18.91
18.76
Profit After Tax
11.2
63.82
16.21
15.57
38.09
42.63
58.19
60.99
Total Net profit including share of profit / Loss from associate company
11.2
63.82
16.21
15.57
38.09
42.63
58.19
60.99
EPS
7.06
38.61
8.9
8.7
18.58
19.7
27.97
29.19
Actual EPS
7.06
38.61
8.9
8.7
18.58
19.7
27.97
29.19
Adjusted EPS
4.97
27.19
6.27
6.13
18.58
19.7
27.97
29.19
Diluted EPS
6.8
37.65
8.9
8.7
18.58
19.7
27.88
28.87

Windlas Biotech Ltd Cash Flow

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
34.88
18.65
25.01
11.46
9.13
60.97
108.96
68.19
Cash Flow from Investing Activities
-10.99
-6.77
-14.34
-20.19
-154.58
-14.11
-92.07
-74.06
Cash Flow from Financing Activities
-26.05
-6.22
-5.44
0.77
130.07
-43.75
-15.29
1.02
Net Cash Flow
-2.16
5.66
5.22
-7.97
-15.36
3.12
1.6
-4.86

Windlas Biotech Stock Shareholding Pattern

Numbers in percentages

Apr 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
62.44%
62.82%
62.82%
62.82%
62.82%
62.51%
62.51%
62.51%
62.34%
62.34%
61.99%
61.99%
DII
11.64%
11.53%
10.47%
11.71%
11.82%
10.35%
9.58%
10.26%
10.89%
11.21%
11.43%
11.44%
FII
0%
0%
0%
1.35%
1.18%
1.59%
2%
1.55%
1.52%
1.44%
1.11%
0.93%
Public
24.68%
24.85%
24.85%
24.12%
24.19%
25.55%
25.91%
25.68%
25.25%
25.01%
25.47%
25.64%
Total Outstanding Shares
2,09,23,058
2,07,98,575
2,07,98,575
2,07,98,575
2,07,98,575
2,09,00,311
2,09,00,311
2,09,00,311
2,09,59,311
2,09,59,311
2,10,77,239
2,10,77,239
Total Shareholders
78,829
75,470
68,798
61,900
51,277
45,824
45,706
46,590
46,383
45,887
45,433
45,461

Mutual Funds that own Windlas Biotech Stock

Check out the Mutual Funds with significant holdings in Windlas Biotech.

Windlas Biotech Corporate Actions

View detailed summary of the earnings and dividend history of Windlas Biotech.

  • Windlas Biotech Ltd Earnings Results

    Windlas Biotech Ltd’s net profit fell -3.72% since last year same period to ₹15.00Cr in the Q3 2025-2026. On a quarterly growth basis, Windlas Biotech Ltd has generated -15.73% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Windlas Biotech Ltd Dividends May,2025

    In the quarter ending March 2025, Windlas Biotech Ltd has declared dividend of ₹5.80 per share on 22 May 2025 - translating a dividend yield of 0.74%.

    Read More about Dividends

Indices Featuring Windlas Biotech Stock

Check stock indices that include Windlas Biotech.

BSE Healthcare

₹42,427.96

-0.73 (▲311.37%)

Insights on Windlas Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 13 quarters, 121.87 Cr → 237.67 Cr (in ₹), with an average increase of 5.4% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 6.39% to 6.63% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 25.47% to 25.64% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, WINDLAS stock has moved up by 7.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 32.9% return, outperforming this stock by 58.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 61.99% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.11% to 0.93% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 17.8 Cr → 15.0 Cr (in ₹), with an average decrease of 15.7% per quarter

About Windlas Biotech Ltd

Windlas Biotech Ltd was founded in 2001 and is a leading provider of pharmaceutical services, development, manufacturing services, and products. The company has a manufacturing plant in Dehradun, Uttarakhand, India and a sales force and distribution network across 14 states. Additionally, it provides CDMO services and products, domestic trade generics and OTC brands, and exports. The company specializes in complex generics products and fixed dose combinations linked to lifestyle-related diseases, as well as drug-device combos. It has adopted high quality systems across its factories and processes that span from product innovation to customer intake. In addition to this, multiple vendors are approved and assessed for sourcing the raw materials.

Revenue: ₹233.10Cr as on December 2025 (Q3 FY26)
Net Profit: ₹15.00Cr as on December 2025 (Q3 FY26)
Listing date: 16 Aug, 2021
Chairperson Name: Vivek Dhariwal
OrganisationWindlas Biotech Ltd
HeadquartersGurgaon
IndustryPharmaceuticals
CEOVivek Dhariwal
E-voting on sharesClick here to vote

FAQs

What is Windlas Biotech share price today?

Windlas Biotech share price today stands at ₹765 as on at the close of the market. Windlas Biotech share today touched a day high of ₹779 and a low of ₹747.1.

What is the 52 week high and 52 week low range for Windlas Biotech share?

Windlas Biotech touched a 52 week high of ₹1140 and a 52 week low of ₹697.4. Windlas Biotech share price today i.e. is closed at ₹765, which is -32.89% down from its 52 week high and 9.69% up from its 52 week low.

What is Windlas Biotech's market capitalisation today?

Windlas Biotech market capitalisation is ₹1,646.60 Cr as on .

How to buy Windlas Biotech shares?

To buy Windlas Biotech shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for WINDLAS or Windlas Biotech Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Windlas Biotech shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Windlas Biotech trading volume today?

Windlas Biotech trading volume is 49.12K as on . This means that 49.12K shares of Windlas Biotech were bought and sold on the stock market during today's trading session.